Clinical Insights
GP-authored articles on the markers, mechanisms, and interventions that matter most for people who want to act early — before dysfunction becomes disease.
Homocysteine is an independent cardiovascular and cognitive risk marker not included in standard NHS panels. Elevated levels are most commonly caused by low folate or B12 — yet they silently drive endothelial damage, inflammation, and vascular risk that conventional screening completely misses.
Three independent atherogenic pathways your standard NHS cholesterol panel does not measure — and why having all three elevated compounds your risk in ways that standard screening completely misses.
LDL cholesterol is still the headline number on most lipid panels, but ApoB often gives the cleaner answer to the question that actually matters: how many atherogenic particles are circulating through the arterial system?
Fasting glucose and HbA1c can look perfectly normal while hyperinsulinaemia silently drives visceral fat accumulation, fatigue, and vascular risk. Here is what fasting insulin actually tells you, what a normal range looks like, and who should be tested.
Metabolic syndrome affects 1 in 4 UK adults and is among the most reversible of all cardiometabolic conditions. The clinical evidence on reversal is more optimistic than most patients are told. Here is what the data shows and where to start.
Not sure where you stand?
A free clinical screening tool that estimates where your metabolism is tracking — and points you to the most relevant next step.